Trial Profile
Treatment of Chronic HCV With Sofosbuvir and Simeprevir in Patients With Cirrhosis and Contraindications to Interferon and/or Ribavirin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 13 Nov 2015 New trial record
- 22 Oct 2014 Interim results (n=75) presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology